V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260006326 | 260011223 | 1.54 | 84 | Adjuvant (A) | 2015-08-06 | 2015-08-06 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023631 | BENDAMUSTINE + RITUXIMAB |
| 260006327 | 260004671 | 1.62 | 45.8 | Not known (9) | 2015-04-29 | 2015-05-08 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023632 | BENDAMUSTINE + RITUXIMAB |
| 260006328 | 260004671 | null | null | null | 2015-02-15 | 2015-02-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023632 | BENDAMUSTINE + RITUXIMAB |
| 260006329 | 260004672 | 1.71 | 74.8 | Palliative (P) | 2015-02-09 | 2015-02-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023635 | BENDAMUSTINE + RITUXIMAB |
| 260006330 | 260004672 | 1.65 | 56.5 | Disease modification (D) | 2016-04-17 | 2016-05-15 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023635 | BENDAMUSTINE + RITUXIMAB |
| 260006331 | 260004672 | 1.77 | 146 | Palliative (P) | 2014-01-13 | 2014-01-14 | BENDAMUSTINE + RITUXIMAB | N | N | 260023635 | BENDAMUSTINE + RITUXIMAB |
| 260006332 | 260004673 | 1.76 | 88.5 | Curative (C) | null | 2016-07-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260023640 | BENDAMUSTINE + RITUXIMAB |
| 260006333 | 260004674 | 1.62 | 74.3 | Curative (C) | 2014-03-14 | 2014-03-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023642 | BENDAMUSTINE + RITUXIMAB |
| 260006334 | 260004674 | 1.78 | 74.2 | null | 2015-05-14 | 2015-05-21 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023642 | BENDAMUSTINE + RITUXIMAB |
| 260006335 | 260004675 | 1.81 | 112 | Disease modification (D) | null | 2018-05-23 | Bendamustine+Rituximab (1st Course) | N | N | 260023645 | BENDAMUSTINE + RITUXIMAB |
| 260006336 | 260011227 | 1.78 | 87 | Disease modification (D) | 2017-10-31 | 2017-11-19 | BENDAMUSTINE + RITUXIMAB | N | N | 260023646 | BENDAMUSTINE + RITUXIMAB |
| 260006337 | 260004676 | 1.63 | 82 | Palliative (P) | 2016-05-04 | 2016-05-05 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023649 | BENDAMUSTINE + RITUXIMAB |
| 260006338 | 260004676 | 1.73 | 78 | Disease modification (D) | 2013-06-16 | 2013-06-25 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023649 | BENDAMUSTINE + RITUXIMAB |
| 260006339 | 260004676 | 1.77 | 104 | Palliative (P) | null | 2017-10-28 | BENDAMUSTINE + RITUXIMAB | N | N | 260023649 | BENDAMUSTINE + RITUXIMAB |
| 260006340 | 260004676 | 1.73 | 86 | Palliative (P) | 2015-03-08 | 2015-03-08 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023649 | BENDAMUSTINE + RITUXIMAB |
| 260006341 | 260004677 | 1.7 | 75.1 | Disease modification (D) | null | 2016-09-25 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023656 | BENDAMUSTINE + RITUXIMAB |
| 260006342 | 260004677 | 1.64 | 61.8 | Palliative (P) | 2013-03-19 | 2013-03-19 | Bendamustine+Rituximab (1st Course) | N | N | 260023656 | BENDAMUSTINE + RITUXIMAB |
| 260006343 | 260004677 | 1.76 | 91 | Palliative (P) | 2017-07-11 | 2017-07-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023656 | BENDAMUSTINE + RITUXIMAB |
| 260006344 | 260004677 | 1.83 | 108 | Palliative (P) | 2017-11-04 | 2017-11-19 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260023656 | BENDAMUSTINE + RITUXIMAB |
| 260006345 | 260018330 | 1.55 | 37.7 | Disease modification (D) | 2017-03-22 | 2017-03-22 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023663 | BENDAMUSTINE + RITUXIMAB |
| 260006346 | 260018871 | 1.79 | 92.15 | null | 2017-04-03 | 2017-04-06 | BENDAMUSTINE + RITUXIMAB | N | N | 260023664 | BENDAMUSTINE + RITUXIMAB |
| 260006347 | 260018871 | 1.65 | 85.8 | Disease modification (D) | 2015-02-11 | 2015-02-11 | BENDAMUSTINE + RITUXIMAB | N | N | 260023664 | BENDAMUSTINE + RITUXIMAB |
| 260006348 | 260018871 | 1.69 | 81.4 | Disease modification (D) | 2014-04-07 | 2014-04-07 | BENDAMUSTINE + RITUXIMAB | N | N | 260023664 | BENDAMUSTINE + RITUXIMAB |
| 260006352 | 260004679 | 1.66 | 100.4 | Disease modification (D) | 2018-04-17 | 2018-04-18 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023676 | BENDAMUSTINE + RITUXIMAB |
| 260006353 | 260004680 | 1.75 | 80 | Disease modification (D) | 2013-10-15 | 2013-10-18 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023677 | BENDAMUSTINE + RITUXIMAB |
| 260006354 | 260004681 | 1.65 | 54.9 | Curative (C) | 2014-06-27 | 2014-07-12 | BENDAMUSTINE + RITUXIMAB | N | N | 260023678 | BENDAMUSTINE + RITUXIMAB |
| 260006355 | 260004681 | 1.76 | 84.9 | Curative (C) | 2019-03-21 | 2019-03-23 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023678 | BENDAMUSTINE + RITUXIMAB |
| 260006356 | 260004681 | 1.73 | 80 | Disease modification (D) | 2013-01-12 | 2013-02-01 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023678 | BENDAMUSTINE + RITUXIMAB |
| 260006357 | 260004682 | 1.78 | 90 | Disease modification (D) | 2013-05-22 | 2013-05-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260023689 | BENDAMUSTINE + RITUXIMAB |
| 260006358 | 260004683 | 1.73 | 103 | Palliative (P) | 2017-05-24 | 2017-05-28 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023690 | BENDAMUSTINE + RITUXIMAB |
| 260006359 | 260004683 | 1.45 | 62.4 | Disease modification (D) | 2015-09-25 | 2015-09-29 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023690 | BENDAMUSTINE + RITUXIMAB |
| 260006360 | 260004684 | 1.61 | 68.9 | Palliative (P) | 2015-09-29 | 2015-10-11 | Bendamustine+Rituximab (1st Course) | N | null | 260023695 | BENDAMUSTINE + RITUXIMAB |
| 260006361 | 260004685 | 1.75 | 84 | Disease modification (D) | null | 2013-05-29 | BENDAMUSTINE + RITUXIMAB | N | N | 260023696 | BENDAMUSTINE + RITUXIMAB |
| 260006362 | 260004685 | 1.61 | 61.7 | Palliative (P) | 2013-12-24 | 2013-12-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260023696 | BENDAMUSTINE + RITUXIMAB |
| 260006363 | 260004686 | 1.85 | 85 | Palliative (P) | 2016-02-17 | 2016-02-28 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023698 | BENDAMUSTINE + RITUXIMAB |
| 260006364 | 260004686 | 1.75 | 100.9 | Disease modification (D) | 2014-01-08 | 2014-01-14 | Bendamustine+Rituximab (1st Course) | N | N | 260023698 | BENDAMUSTINE + RITUXIMAB |
| 260006365 | 260004686 | 1.74 | 100.7 | null | 2013-07-10 | 2013-07-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023698 | BENDAMUSTINE + RITUXIMAB |
| 260006366 | 260004687 | 1.71 | 84.3 | Disease modification (D) | 2013-02-05 | 2013-02-09 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260023703 | BENDAMUSTINE + RITUXIMAB |
| 260006367 | 260004687 | null | null | Curative (C) | 2014-04-29 | 2014-05-11 | BENDAMUSTINE + RITUXIMAB | N | N | 260023703 | BENDAMUSTINE + RITUXIMAB |
| 260006368 | 260004688 | 1.83 | 76.4 | null | 2014-07-12 | 2014-07-18 | BENDAMUSTINE + RITUXIMAB | N | N | 260023711 | BENDAMUSTINE + RITUXIMAB |
| 260006369 | 260004689 | 1.84 | 73.4 | Palliative (P) | 2013-03-31 | 2013-04-01 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023712 | BENDAMUSTINE + RITUXIMAB |
| 260006370 | 260004690 | 1.53 | 58.4 | Disease modification (D) | 2017-05-25 | 2017-05-25 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023715 | BENDAMUSTINE + RITUXIMAB |
| 260006371 | 260004691 | null | 63.3 | Palliative (P) | 2017-01-04 | 2017-01-26 | BENDAMUSTINE + RITUXIMAB | N | null | 260023716 | BENDAMUSTINE + RITUXIMAB |
| 260006372 | 260004692 | 1.68 | 73 | Palliative (P) | 2014-12-12 | 2014-12-14 | BENDAMUSTINE + RITUXIMAB | N | Y | 260023717 | BENDAMUSTINE + RITUXIMAB |
| 260006373 | 260004693 | 1.72 | 62 | Palliative (P) | 2015-06-10 | 2015-06-15 | BENDAMUSTINE + RITUXIMAB | N | N | 260023719 | BENDAMUSTINE + RITUXIMAB |
| 260006374 | 260004694 | 1.85 | 92 | Curative (C) | 2016-01-03 | 2016-01-05 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023720 | BENDAMUSTINE + RITUXIMAB |
| 260006375 | 260004695 | 1.75 | 90.8 | Not known (9) | 2014-10-31 | 2014-11-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023722 | BENDAMUSTINE + RITUXIMAB |
| 260006376 | 260004696 | null | 81 | Curative (C) | null | 2014-07-22 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023724 | BENDAMUSTINE + RITUXIMAB |
| 260006377 | 260004697 | 1.67 | 85.7 | Disease modification (D) | 2014-09-11 | 2014-09-21 | BENDAMUSTINE + RITUXIMAB | N | N | 260023726 | BENDAMUSTINE + RITUXIMAB |
| 260006378 | 260004697 | null | 50 | Disease modification (D) | 2017-04-12 | 2017-04-13 | BENDAMUSTINE + RITUXIMAB | N | N | 260023726 | BENDAMUSTINE + RITUXIMAB |